Header Logo

Neilayan Sen

Concepts (71)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Radiation Oncology
3
2019
14
0.460
 Why?
Pancreatic Neoplasms
1
2014
93
0.410
 Why?
Employment
2
2018
38
0.290
 Why?
Chemoradiotherapy
2
2019
61
0.260
 Why?
Sarcoma
2
2019
148
0.230
 Why?
Internship and Residency
2
2019
215
0.230
 Why?
Carcinoma, Non-Small-Cell Lung
2
2017
240
0.220
 Why?
Lung Neoplasms
2
2017
551
0.180
 Why?
Human papillomavirus 16
1
2019
6
0.160
 Why?
Oropharyngeal Neoplasms
1
2019
20
0.160
 Why?
Biopsy, Fine-Needle
1
2019
63
0.150
 Why?
Career Choice
1
2018
26
0.150
 Why?
Tongue Neoplasms
1
2018
19
0.150
 Why?
Neoadjuvant Therapy
2
2019
65
0.150
 Why?
Carcinoma, Squamous Cell
1
2019
172
0.140
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2019
245
0.140
 Why?
Radiosurgery
1
2017
37
0.140
 Why?
Brachytherapy
1
2016
46
0.130
 Why?
Prognosis
2
2019
804
0.130
 Why?
Radiotherapy, Adjuvant
1
2014
52
0.110
 Why?
United States
4
2019
2054
0.100
 Why?
Humans
10
2019
27114
0.100
 Why?
Retrospective Studies
4
2019
3542
0.080
 Why?
Treatment Outcome
4
2019
3528
0.080
 Why?
Chi-Square Distribution
2
2018
138
0.070
 Why?
Male
6
2019
14793
0.070
 Why?
Female
6
2019
15234
0.070
 Why?
Disease-Free Survival
2
2018
179
0.070
 Why?
Databases, Factual
2
2019
350
0.070
 Why?
Neoplasm Staging
2
2018
368
0.060
 Why?
Adult
4
2019
7899
0.060
 Why?
Cohort Studies
2
2019
1895
0.050
 Why?
Aged
3
2019
9060
0.040
 Why?
Genetic Heterogeneity
1
2019
9
0.040
 Why?
Mesna
1
2019
3
0.040
 Why?
Population Density
1
2018
7
0.040
 Why?
Job Application
1
2018
6
0.040
 Why?
Ifosfamide
1
2019
13
0.040
 Why?
Cities
1
2018
17
0.040
 Why?
Clinical Decision-Making
1
2019
46
0.040
 Why?
Organ Sparing Treatments
1
2019
12
0.040
 Why?
Reference Values
1
2019
185
0.040
 Why?
Schools, Medical
1
2018
27
0.040
 Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2018
29
0.040
 Why?
Consumer Behavior
1
2018
23
0.040
 Why?
Leg
1
2019
50
0.040
 Why?
Doxorubicin
1
2019
57
0.040
 Why?
Arm
1
2019
83
0.040
 Why?
Neoplasm Invasiveness
1
2018
93
0.040
 Why?
Combined Modality Therapy
1
2019
305
0.040
 Why?
Analysis of Variance
1
2018
256
0.040
 Why?
Professional Practice Location
1
2017
2
0.030
 Why?
Survival Rate
1
2018
344
0.030
 Why?
Academies and Institutes
1
2017
11
0.030
 Why?
Censuses
1
2017
9
0.030
 Why?
Radiotherapy Dosage
1
2017
100
0.030
 Why?
Patient Safety
1
2017
38
0.030
 Why?
Kaplan-Meier Estimate
1
2017
177
0.030
 Why?
Risk Assessment
1
2019
628
0.030
 Why?
Societies, Medical
1
2017
123
0.030
 Why?
Registries
1
2017
193
0.030
 Why?
Age Factors
1
2018
772
0.030
 Why?
Middle Aged
2
2019
9009
0.030
 Why?
Chemoradiotherapy, Adjuvant
1
2015
17
0.030
 Why?
Survival Analysis
1
2015
260
0.030
 Why?
Surveys and Questionnaires
1
2018
1155
0.030
 Why?
Adolescent
1
2018
2177
0.020
 Why?
Young Adult
1
2018
2022
0.020
 Why?
Prospective Studies
1
2017
1773
0.020
 Why?
Follow-Up Studies
1
2017
1798
0.020
 Why?
Aged, 80 and over
1
2017
4818
0.020
 Why?
Sen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (71)
Explore
_
Co-Authors (19)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_